Treatment Satisfaction in Implantable Cardioverter Defibrillator Recipients

NCT ID: NCT01230073

Last Updated: 2018-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Remote monitoring of implantable cardioverter defibrillators (ICD) is a promising new development in ICD therapy and has been shown to be technically feasible and safe.While data on safety and feasibility of remote monitoring are in favour of this technology, patients´ treatment satisfaction has not been sufficiently investigated. To date, there is only one small, non-randomised study investigating patients´ treatment satisfaction in highly selected and highly motivated patients at the time of implantation and 12 months thereafter7. Therefore, the aim of the San Remo Trial is to investigate factors that are associated with patients´ willingness to accept the new method of follow-up on a broad basis of ICD recipients and to determine their treatment satisfaction with ICD therapy in a randomised, prospective trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Improvement of Treatment Satisfaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICD traditional follow-up

ICD with traditional follow-up in the outpatient clinic

Group Type ACTIVE_COMPARATOR

Home-Monitoring

Intervention Type DEVICE

Home-Monitoring

Follow-up by Home-Monitoring

Intervention Type DEVICE

Follow-up by Home-Monitoring

Home-Monitoring

Home-Monitoring

Group Type ACTIVE_COMPARATOR

Home-Monitoring

Intervention Type DEVICE

Home-Monitoring

Follow-up by Home-Monitoring

Intervention Type DEVICE

Follow-up by Home-Monitoring

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home-Monitoring

Home-Monitoring

Intervention Type DEVICE

Follow-up by Home-Monitoring

Follow-up by Home-Monitoring

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ICD indication according to current national or international guidelines
* Patient available for follow-up during study period

Exclusion Criteria

* Clinically unstable medical conditions that require regular outpatient clinic follow-up
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deutsches Herzzentrum Muenchen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kolb Christof

Role: PRINCIPAL_INVESTIGATOR

Deutsches Herzzentrum

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Deutsches Hezzentrum

München, Bavaria, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GER-EP-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

In-depth Interviews of Patients With ICDs
NCT07258602 ENROLLING_BY_INVITATION
Novel ICD Arrhythmia Detection Algorithm
NCT04981496 ACTIVE_NOT_RECRUITING
CRT-P or CRT-D in Dilated Cardiomyopathy
NCT04139460 NOT_YET_RECRUITING NA